Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer's disease

Acta Neuropathologica

Volumn 120, Issue 2, 2010, Pages 185-193

  Portelius, Erik ^a   Bogdanovic, Nenad ^b   Gustavsson, Mikael K ^a   Volkmann, Inga ^b   Brinkmalm, Gunnar ^a   Zetterberg, Henrik ^a   Winblad, Bengt ^b   Blennow, Kaj ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Brain; Immunoprecipitation; Mass spectrometry

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN[3-42]; AMYLOID BETA PROTEIN[4-42]; AMYLOID PRECURSOR PROTEIN; GLUTAMIC ACID; ISOPROTEIN; METHIONINE; PRESENILIN; UNCLASSIFIED DRUG; VALINE; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL ALZHEIMER DISEASE; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; MALE; MASS SPECTROMETRY; MUTATIONAL ANALYSIS; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; SPORADIC ALZHEIMER DISEASE; BRAIN; CLASSIFICATION; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; STATISTICS;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BRAIN; FEMALE; HUMANS; IMMUNOPRECIPITATION; MALE; MASS SPECTROMETRY; MIDDLE AGED; PEPTIDE FRAGMENTS; PROTEIN ISOFORMS; STATISTICS AS TOPIC;

EID: 77957279325     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-010-0690-1     Document Type: Article

References (40)

1. Andreasson U, Portelius E, Andersson ME, Blennow K, Zetterberg H (2007) Aspects of beta-amyloid as a biomarker for Alzheimer's disease. Biomark Med 1: 59-78
2. Bogdanovic N, Corder E, Lannfelt L, Winblad B (2002) APOE polymorphism and clinical duration determine regional neuropathology in Swedish APP(670, 671) mutation carriers: implications for late-onset Alzheimer's disease. J Cell. Mol Med 6: 199-214
3. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239-259
4. Brouwers N, Sleegers K, Van Broeckhoven C (2008) Molecular genetics of Alzheimer's disease: an update. Ann Med 40: 562-583
5. De Strooper B (2003) Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex. Neuron 38: 9-12
6. Dickson DW (1997) The pathogenesis of senile plaques. J Neuropathol Exp Neurol 56: 321-339
7. Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Ol-tersdorf T, McClure D, Ward PJ (1990) Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science 248: 1122-1124
8. Glenner GG, Wong CW (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120: 885-890 (Pubitemid 14104991)
9. Gouras GK, Xu H, Jovanovic JN, Buxbaum JD, Wang R, Greengard P, Relkin NR, Gandy S (1998) Generation and regulation of beta-amyloid peptide variants by neurons. J Neurochem 71: 1920-1925
10. Gowing E, Roher AE, Woods AS, Cotter RJ, Chaney M, Little SP, Ball MJ (1994) Chemical characterization of A beta 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease. J Biol Chem 269: 10987-10990
11. Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL, Lieberburg I, Koo EH, Schenk D, Teplow DB et al (1992) Amyloid beta-peptide is produced by cultured cells during normal metabolism.. Nature 359: 322-325
12. Haass C, Hung AY, Schlossmacher MG, Teplow DB, Selkoe DJ (1993) beta-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J Biol Chem 268: 3021-3024
13. Haass C, Lemere CA, Capell A, Citron M, Seubert P, Schenk D, Lannfelt L, Selkoe DJ (1995) The Swedish mutation causes earlyonset Alzheimer's disease by beta-secretase cleavage within the secretory pathway. Nat Med 1: 1291-1296
14. Haltia M, Viitanen M, Sulkava R, Ala-Hurula V, Poyhonen M, Goldfarb L, Brown P, Levy E, Houlden H, Crook R et al (1994) Chromosome 14-encoded Alzheimer's disease: genetic and clinicopathological description. Ann Neurol 36: 362-367
15. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353-356
16. Harigaya Y, Saido TC, Eckman CB, Prada CM, Shoji M, Younkin SG (2000) Amyloid beta protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer's disease brain. Biochem Biophys Res Commun 276: 422-427
17. Harvey RJ, Skelton-Robinson M, Rossor MN (2003) The prevalence and causes of dementia in people under the age of 65 years. J Neurol Neurosurg Psychiatry 74: 1206-1209 (Pubitemid 37152242)
18. Hussain I, Powell D, Howlett DR, Tew DG, Meek TD, Chapman C, Gloger IS, Murphy KE, Southan CD, Ryan DM, Smith TS, Simmons DL, Walsh FS, Dingwall C, Christie G (1999) Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol Cell Neurosci 14: 419-427 (Pubitemid 30026585)
19. Jager S, Leuchtenberger S, Martin A, Czirr E, Wesselowski J, Dieckmann M, Waldron E, Korth C, Koo EH, Heneka M, Weggen S, Pietrzik CU (2009) Alpha-secretase mediated conversion of the amyloid precursor protein derived membrane stub C99 to C83 limits Abeta generation. J Neurochem 111(6): 1369-1382
20. Lalowski M, Golabek A, Lemere CA, Selkoe DJ, Wisniewski HM, Beavis RC, Frangione B, Wisniewski T (1996) The "nonamyloidogenic" p3 fragment (amyloid betal7-42) is a major constituent of Down's syndrome cerebellar preamyloid. J Biol Chem 271: 33623-33631
21. Lannfelt L, Bogdanovic N, Appelgren H, Axelman K, Lilius L, Hansson G, Schenk D, Hardy J, Winblad B (1994) Amyloid precursor protein mutation causes Alzheimer's disease in a Swedish family. Neurosci Lett 168: 254-256 (Pubitemid 24097370)
22. Mackenzie IR, McLachlan RS, Kubu CS, Miller LA (1996) Prospective neuropsychological assessment of nondemented patients with biopsy proven senile plaques. Neurology 46: 425-429
23. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944
24. Miravalle L, Calero M, Takao M, Roher AE, Ghetti B, Vidal R (2005) Amino-terminally truncated Abeta peptide species are the main component of cotton wool plaques. Biochemistry 44: 10810-10821
25. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479-486
26. Naslund J, Schierhorn A, Hellman U, Lannfelt L, Roses AD, Tjernberg LO, Silberring J, Gandy SE, Winblad B, Greengard P et al (1994) Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging. Proc Natl Acad Sci USA 91: 8378-8382 (Pubitemid 24273667)
27. Piccini A, Russo C, Gliozzi A, Relini A, Vitali A, Borghi R, Giliberto L, Armirotti A, D'Arrigo C, Bachi A, Cattaneo A, Canale C, Torrassa S, Saido TC, Markesbery W, Gambetti P, Tabaton M (2005) beta-amyloid is different in normal aging and in Alzheimer disease. J Biol Chem 280: 34186-34192 (Pubitemid 41443143)
28. Pike CJ, Overman MJ, Cotman CW (1995) Ami no-terminal deletions enhance aggregation of beta-amyloid peptides in vitro. J Biol Chem. 270: 23895-23898
29. Portelius E, Tran AJ, Andreasson U, Persson R, Brinkmalm G, Zetterberg H, Blennow K, Westman-Brinkmalm A (2007) Characterization of amyloid beta peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry. J Proteome Res 6: 4433-4439
30. Portelius E, Brinkmalm G, Tran AJ, Zetterberg H, WestmanBrinkmalm A, Blennow K (2009) Identification of novel APP/ Abeta isoforms in human cerebrospinal fluid. Neurodegener Dis 6: 87-94
31. Portelius E, Price E, Brinkmalm G, Stiteler M, Olsson M, Persson R, Westman-Brinkmalm A, Zetterberg H, Simon AJ, Blennow K (2009) A novel pathway for amyloid precursor protein processing. Neurobiol Aging. doi:10.1016/j. neurobiolaging.2009.06.002
32. Portelius E, Zhang B, Gustavsson MK, Brinkmalm G, WestmanBrinkmalm A, Zetterberg H, Lee VM, Trojanowski JQ, Blennow K (2009) Effects of gamma-secretase inhibition on the amyloid beta isoform pattern in a mouse model of Alzheimer's disease. Neurodegener Dis 6: 258-262
33. Shen J, Kelleher RJ III (2007) The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism. Proc Natl Acad Sci USA 104: 403-409 (Pubitemid 46123039)
34. Sinha S, Anderson JP, Barbour R, Basi GS, Caccavello R, Davis D, Doan M, Dovey HF, Frigon N, Hong J, Jacobson-Croak K, Jewett N, Keim P, Knops J, Lieberburg I, Power M, Tan H, Tatsuno G, Tung J, Schenk D, Seubert P, Suomensaari SM, Wang S, Walker D, Zhao J, McConlogue L, John V (1999) Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 402: 537-540
35. Tekirian TL (2001) Commentary: A beta N-terminal isoforms: critical contributors in the course of AD pathophysiology. J Alzheimers Dis 3: 241-248
36. Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A betadeposition in the human brain and its relevance for the development of AD. Neurology 58: 1791-1800 (Pubitemid 34663580)
37. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, Collins F, Treanor J, Rogers G, Citron M (1999) Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286: 735-741
38. Welander H, Franberg J, Graff C, Sundstrom E, Winblad B, Tjemberg LO (2009) Abeta43 is more frequent than Abeta40 in amyloid plaque cores from Alzheimer disease brains. J Neurochem 110: 697-706
39. Yan R, Bienkowski MJ, Shuck ME, Miao H, Tory MC, Pauley AM, Brashier JR, Stratman NC, Mathews WR, Buhl AE, Carter DB, Tomasselli AG, Parodi LA, Heinrikson RL, Gurney ME (1999) Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 402: 533-537
40. Zellner M, Veitinger M, Umlauf E (2009) The role of proteomics in dementia and Alzheimer's disease. Acta Neuropathol 118: 181-195